Clinical Investigation for a Multifunction Ophthalmic Measurement Device

NCT ID: NCT06565091

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

378 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-10

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical investigation is to evaluate the clinical utility of a multifunctional measuring device for Ophtalmology.

The results of this clinical investigation will be used to refine and validate the device design.

378 participants total will be included in the trial, each having only one visit at the investigation center.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this clinical investigation are:

* Develop the device in clinical conditions (refine the intensity and gain of the light sources and the acquisition time of the cameras and photodiodes, in order to cover the targeted population).
* Evaluate the safety and clinical performance and/or effectiveness of the medical device and determine whether the system is suitable for the purposes and populations for which it is intended.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Accommodation Disorder Keratoconus Dry Eye Refractive Errors Accommodative Fatigue Accommodative Inertia Aberration, Corneal Wavefront

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multifonction Ophtalmic Measuring Device

Parameters and images of the anterior and posterior chambers of the human eye

Group Type EXPERIMENTAL

Measurements of physiological parameters of the anterior chamber

Intervention Type DEVICE

Acquisition by the investigational device

Measurements of the Axial biometry

Intervention Type DEVICE

Acquisition by the investigational device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurements of physiological parameters of the anterior chamber

Acquisition by the investigational device

Intervention Type DEVICE

Measurements of the Axial biometry

Acquisition by the investigational device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adults ≥ 18 years old and Healthy children\* ≥ 4 years and \<18 of age.

Participants initially coming to the center for a routine consultation

Participants who are affiliated to a social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique"),

Participants able to sit upright in front of the investigational device.


Healthy children ≥ 4 years and \<18 of age. The parents must have consented to their child's participation.

Children who are affiliated to parent's social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique")

Children initially coming to the center for a routine consultation

Children able to sit upright in front of the instrument.

Exclusion Criteria

Participants with implanted electronic medical device such as pacemaker, insulin pump, cochlear implant, electrostimulator or hearing aid,

Participants not able to sit upright in front of the instrument or subjects with forehead or chin injuries which prevent the head from being supported on the forehead / chin rest.

Participants who are deprived of their liberty by judicial or administrative decision and persons hospitalized without their consent (Article L. 1121-6 of "Code de Santé Publique"),

Participants who are subject to a legal protection measure (curatorship, guardianship, safeguard of justice ...) or unable to express their consent (Article L1121-8 of "Code de Santé Publique"),

Participants who are not affiliated to a social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique"),

Participants under exclusion period from another investigation,

Women who are pregnant or breastfeeding women; (Article L1121-5 of "Code de Santé Publique"). No additional risk had been identified for pregnant woman in participating in the investigation. Nevertheless, pregnancy induces ocular changes: in case of AE, the causality with the device or with pregnancy may be difficult to establish, justifying the non-inclusion of this population.

Participants with neurologic disorder, particularly epileptic or sensory motor troubles,

Participants with history of recent ocular surgeries (including refractive surgery less than 2 weeks),

Participants who are ESSILOR International/ESSILOR Luxottica employees,

Participants with monophthalmia,

Participants with obvious fixation disorder, strabismus, or nystagmus,

For tonometry measurements: subjects who have: Edematous/ulcerated cornea, following keratoplasty or ocular surgery, following penetrating trauma, severe Keratoconus with risk of hydrops and in case of retinal detachment. Anterior and posterior chamber sulcus IOL, intrastromal rings or lens (type Kamra).

Participants with pupil \< 2 mm,

Participants who are with spherical equivalent refraction out of the range -20.00 to + 20.00 D (frontofocometer measurement),

Participants with an astigmatism greater than 8.00 D (\<8.00 D) (frontofocometer measurement),

Participants with corneal power out of the range \[35-55D\],

Participants with axial length out of the range \[18-34 mm\],

Participants with Intraocular pressure out of \[7-50 mm Hg\] range,

Participants to a previous phase of this clinical investigation.


Children with neurologic disorders, particularly epileptic or sensory motor troubles,

Children with history of recent ocular surgeries (including refractive surgery less than two weeks)

Children with monophthalmia,

Children with obvious fixation disorder, strabismus, or nystagmus,

Children with pupil \< 2 mm

Children with a spherical equivalent refraction out of the range \[-20.00 to + 20.00 D\] (frontofocometer measurement),

Children with an astigmatism higher than 8.00 D (\>8.00 D)

Children with axial length out of the range \[18-34 mm\]
Minimum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Essilor International

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François LE GUYADER, Dr

Role: PRINCIPAL_INVESTIGATOR

WEST OPHTA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West Ophta

Rennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paul-Henri Prevot

Role: CONTACT

+33 1 72 94 70 09

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

FRANCOIS LE GUYADER, Dr

Role: primary

PIERRE-EMMANUEL ARCADE, Dr

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01481-44

Identifier Type: OTHER

Identifier Source: secondary_id

WS10339

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Axial Length With Adult Onset Myopia (ALWAOM)
NCT05559567 ENROLLING_BY_INVITATION NA
The Berkeley Orthokeratology Study
NCT00000123 COMPLETED PHASE3
Myopia Control Spectacle Lens Cessation Study
NCT05893979 ACTIVE_NOT_RECRUITING NA
Changes in Eye Shape With Myopia Management Interventions
NCT06450132 ACTIVE_NOT_RECRUITING PHASE4